Therapeutic Strategies in COPDFocus on Patient Characteristics and Drug
Delivery
The Burden of COPD
The Burden of COPD (cont)
Impact of COPD Exacerbations
Therapies Used in COPD
Goals of Therapy
Personalize Therapy
Risk Assessment
Risk Assessment (cont)
Strategies to Reduce the Risk of Acute Exacerbations of COPD
Therapies to Reduce the Risk of Acute Exacerbations of COPD
Factors to Consider When Choosing a Drug Delivery Device
The Significance of Peak Inspiratory Flow Rate (PIFR)
Manual Dexterity and MDIs
Arformoterol: Long-term Safety Data From the 2013 American Thoracic
Society Meeting
Arformoterol: Long-term Safety Data From the 2013 American Thoracic
Society Meeting (cont)
Results
Make et al Data From the 2013 American Thoracic Society Meeting
Results
Efficacy and Safety of the Once-Daily Inhaled Umeclidinium/Vilanterol
Combination in COPD
Results
Long-term Safety Study of Aclidinium/Formoterol
Summary of Advances in COPD
Abbreviations
References
References (cont)
References (cont)
Recommended
